The study focuses on the hospital-based local formulation of dairy legume-based therapeutic food as a strategy for managing severe acute malnutrition among children aged 6 to 59 months.
Not Applicable
Not yet recruiting
- Conditions
- Nutritional, Metabolic, Endocrine
- Registration Number
- PACTR202309487179676
- Lead Sponsor
- Tamimu Yakubu
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 140
Inclusion Criteria
SAM children between 6–59 months without allergies to milk or legumes (i.e. peanut)
Children admitted at the ward
Stable SAM cases
Exclusion Criteria
Children will be excluded if they are involved in another research trial or feeding program
Children with chronic debilitating illness (e.g., cerebral palsy or congenital malformations)
Children with history of peanut or milk allergy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the efficacy of dairy legume-based therapeutic food in treating severe acute malnutrition?
How does hospital-based local formulation of therapeutic food compare to standard ready-to-use therapeutic food in efficacy and cost for children with SAM?
Are there specific biomarkers that can predict response to locally prepared therapeutic food in 6-59 month old children with SAM?
What are the potential adverse events associated with dairy legume-based therapeutic food and how can they be managed?
What are the key differences in nutritional composition between locally formulated therapeutic food and gold standard formulas for treating severe acute malnutrition?